Pfizer’s Clinical Trial Data: The Vaccine Causes The Recipients To Develop Acquired Immunodeficiency Syndrome (AIDS)
Pfizer’s latest clinical trial data shows a different perspective
The Pfizer Phase I-II-III clinical trial data showed a terrible outcome
Join Our Telegram channel here: https://t.me/TheTrueReporter
The Sepsis death rate in the 21,926 double vaccinated individuals of the Pfizer Phase III Clinical trial was 21 times higher than usual. That’s not all. The cardiovascular death rate was twice higher than usual.
Check out the table of Pfizer trial deaths from Dose 1 (July 2020) to un-blinding after 6 months (January 2021).
“Sepsis/Septicemia results from an immune system failing to defeat a microbial (viral yeast or bacterial) infection.
Emphysematous cholecystitis is a relatively rare variant of acute cholecystitis with infection by gas-producing organisms. Diagnosis involves the demonstration of gas within the lumen or wall of the gallbladder by ultrasound or CT scan. In contrast to acute cholecystitis, emphysematous cholecystitis occurs more commonly in elderly and diabetic patients and is frequently associated with perforation and death. – https://pubmed.ncbi.nlm.nih.gov/12768870/
It is the result of an immune system failure to defeat a microbial (viral yeast or bacterial) infection.
Acute Cholecystitis. The most frequent cause of acute cholecystitis is gallstones. Other causes include typhoid fever and a malignant tumour obstructing the biliary tract. The inflammation may be secondary to a systemic sepsis. https://medical-dictionary.thefreedictionary.com/emphysematous+cholecystitis
Acute Cholecystitis is biliary sepsis, a sepsis of the Gall Bladder and bile ducts.”
Here are the deaths in the US in 2020:
“The first thing the jumps out of these figures is that Pfizer trial participants had a death rate of 17/19 per 21,921/6 per 6 months. Whereas the general US population has a death rate of 111.2 per 21,923 per 6 months. So Pfizer trial participants were over 6x less likely to die than the general public.
The age profile of the original selection of participants is advertised to be –
12-15 years old: 2260,
16-17 years old: 754,
18-55 years old: 25,427
56+ year old: 17,879
So Pfizer must have done some extremely heavy exclusions of morbidities to get such an absurdly low mortality figure.
The numbers flag up two major concerns which these days have plenty of other statistical, mass media, clinical and anecdotal evidence to support.
These findings absolutely necessitate further investigation specific to immune system degradation and cardiovascular inflammation. But Pfizer un-blinded the placebo group and permitted them to get vaccinated at the end of the 6 month trial period. So it is difficult to see how we can get any more data from Pfizer.
To that end, here is an edited copy letter recently sent to the UK’s Scientific Advisory Group for Emergencies (SAGE) –
Dear Members of SAGE
I write to inform you of an oversight in your scientific advice on Covid-19.
- As you will all be aware, the only acceptable scientific method for determining the safety or effectiveness of medical intervention is to compare its effect upon a randomly chosen experimental group with a control group preferably of similar size for statistical reasons.
In phase III clinical trials for Pfizer, there were 21,921 participants in the vaccinated group and 21,926 in the placebo group, the control group.
The control group, the placebo group is the yardstick with which we measure the effectiveness of the intervention. Only by comparison with a control group can a researcher determine whether an intervention has a statistically significant effect on an experimental group, and the possibility of drawing a false conclusion is mathematically and precisely defined. This A B comparison between intervention and control groups is called the Scientific Method.
So without a control group, the Scientific method has been abandoned, we are no longer following any science at all, and no statistically valid conclusion can be drawn from the intervention. Instead, science and its method have gone out of the window and we are back in the dark ages of Papal decrees.
- The medium-term (1-3 year) safety or efficacy of the Adenovirus-DNA vaccines and the lipid nanoparticle-mRNA vaccines is not yet known because they have not yet been examined in the general population for more than 10 months.
In this country, the intervention group for these vaccines in the age demographic over 18 years old is now over 90% of the population
Why has the Scientific Advisory Group for Emergencies failed to advise the UK government to follow the scientific method and formulate a commensurate control group that does not take the vaccines?
How are we to assess the effectiveness of these vaccine interventions in the absence of such a group?
How can a group of scientists fail so spectacularly to follow not only ‘the science’ but actually any science at all in what is undoubtedly the most important medical intervention in the UK in the history of science and of medical practice?
May I, therefore, insist in the name of Science that you put your lab coats back on and advise the Government of this country without further delay to preserve all presently unvaccinated people as members of a vastly undersized, underrepresented depleted, and sadly less than a commensurate control group in order that this entire vaccination experiment can actually reach a statistically valid and meaningful conclusion and in order to demonstrate to the government and to the British public and to the world in general – what science actually is?
Furthermore, if you are going to use children as lab rats for the benefit of adults and against the advice of the JCVI, then would you please ensure that only 50% of them are vaccinated and the remaining 50% are kept free of intervention as a properly sized control group in order that we can learn something from the government’s hideous medical experimentation on them.
Yours Scientifically,
A concerned reader”
Join Our Telegram channel here: https://t.me/TheTrueReporter
Source: The True Defender
